Selective cytopheresis devices and related methods thereof
AssigneesThe Regents of the University of Michigan, CytoPherx, Inc.
InventorsH. David Humes, Deborah Buffington
Life of this patent
Estimating the term…
Abstract
The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
Claims43
A method for processing cells contained within a body fluid from a subject with acute renal failure, wherein the cells are primed or activated leukocytes, the method comprising:
- (a) sequestering extracorporeally the cells from the subject;
- and
- (b) treating the cells sequestered during step (a) with a calcium chelator to inhibit release of a pro-inflammatory substance from the cells or to deactivate the cells.
A method of treating a subject with acute renal failure, the method comprising:
- (a) sequestering extracorporeally primed or activated leukocytes in a body fluid from the subject;
- and
- (b) treating the leukocytes sequestered during step (a) with a calcium chelator to inhibit release of a pro-inflammatory substance from the leukocytes or to deactivate the leukocytes.
Dependencies are inferred from the claim text.